Precision medicine moves away from a one-size-fits-all model of care. Instead of developing treatment and prevention strategies for the average patient, it tail...
Continue reading
In the ever-evolving field of rare disease research, it's crucial to remain informed about the latest progress. At Sano, our commitment is to stay ahead of thes...
Continue reading
The volume and complexity of genomic data now available to researchers and clinicians has outpaced the capacity of traditional analytical methods. AI offers a w...
Continue reading
Genetics now shapes how medicines are developed, how patients are diagnosed, and how clinical decisions are made. Yet a persistent gap exists between the pace o...
Continue reading
Health equity, defined as everyone having the opportunity to be as healthy as possible, has long been a primary goal of public health. Still, across the world, ...
Continue reading
The 34th International Symposium on ALS/MND arrived at a moment of real momentum in ALS research. The field has seen a significant expansion in genetic understa...
Continue reading
As we step into a new era of medical innovation, it's crucial to shine a light on diseases that have long remained in the shadows. Amyotrophic lateral sclerosis...
Continue reading
Families affected by ALS urged to join free program to uncover their genetic risk, contribute to research, and access new therapies Sano Genetics launches ‘Ligh...
Continue reading
ALS remains one of the most challenging neurodegenerative diseases, with limited treatment options and a progressive course that affects motor function, breathi...
Continue reading
Metabolic dysfunction-associated steatohepatitis (MASH), previously known as nonalcoholic steatohepatitis (NASH), is a complex liver disease characterized by fa...
Continue reading